PEG-interferon Alfa-2b for acute hepatitis C: A review

Mini-Reviews in Medicinal Chemistry

Volumn 7, Issue 8, 2007, Pages 839-843

  Palumbo, Emilio ^a  

^a Hospital of Sondrio   (Italy)

Author keywords

Acute hepatitis C; HCV; Monotherapy; Peg interferon; Treatment

Indexed keywords

INOSINATE DEHYDROGENASE; MEMBRANE RECEPTOR; PEGINTERFERON ALPHA2B; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE; VIRUS DNA; ALPHA2B INTERFERON; PEGINTERFERON ALFA-2B; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DNA SYNTHESIS INHIBITION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG TOLERABILITY; GENOTYPE; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; REVIEW; STRUCTURE ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS LOAD;

ACUTE DISEASE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; TREATMENT OUTCOME;

EID: 34548183535     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955707781387902     Document Type: Review

References (30)

1. Hoofnagle, J.H. Hepatology, 2002, 36(Suppl. 1), S21.
2. Gerlach, J.T.; Diepolder, H.M.; Zachoval, R.; Gruener, N.H.; Jung, M.C.; Ulsenheimer, A.; Schraut, W.W.; Schirren, C.A.; Waechtler, M.; Backmund, M.; Pape, G.R. Gastroenterology, 2003, 125, 80.
3. Seeff, L.B.; Hoofnagle, J.H. Hepatology, 2002, 36(Suppl. 1), S1.
4. Walsh, K.E. N. Engl. J. Med., 1999, 340, 1228.
5. Freeman, A.J.; Dore, G.J.; Low, M.G.; Thorpe, M.; Van Overhede, J.; Lloyd, A.R.; Marinos, G.; Kaldor, J.M. Hepatology, 2004, 34, 809.
6. El-Serag, H.B. Hepatology, 2002, 36, 74.
7. Poynard, T.; Ratziu, V.; Charlotte, F.; Goodman, Z.; McHutchison, J.; Albrecht, J. J. Hepatol., 2001, 34, 730.
8. Manns, M.P.; McHutchinson, J.G.; Gordon, S.C.; Rustgi, V.K.; Shiffman, M.; Reindollar, R.; Goodmann, Z.D.; Koury, K.; Ling, M.; Albrecht, J.K. Lancet, 2001, 358, 958.
9. Fried, M.W.; Shiffman, M.L.; Reddy, R.; Smith, C.; Marinos, G.; Goncales, F.L.; Haussinger, D.; Diago, M.; Carosi, G.; Dhumeaux, D.; Craxi, A.; Lin, A.; Hoffman, J.; Yu, J. N. Engl. J. Med., 2002, 347, 975.
10. Alberti, A.; Boccato, S.; Uario, A.; Benvegnu, L. Hepatology, 2002, 36, 195.
11. Santantonio, T.; Sinisi, E.; Guastadisegni, A.; Gasalino C.; Mazzola, M.; Gentile, A.; Leandro, G.; Pastore, G. Dig. Liv. Dis., 2003, 35, 104.
12. Hwang, S.J.; Lee, S.D.; Chan, C.Y.; Lu, R.H.; Lo, K.J. J. Hepatol., 1994, 21, 831.
13. Delwaide, J.; Bourgeois, N.; Gerard, C.; Wain, E.; Vaira, D.; Belaiche, J. Hepatology, 1999, 30, 264.
14. Gursoy, M.; Gur, G.; Arslan, H.; Ozdemir, N.; Boyacioglu, S. J. Viral. Hepat., 2001, 8, 70.
15. Fabris, P.; Tositti, G.; Giordani, M.T.; Infantolino, D.; de Lalla, F. Am. J. Gastroenterol., 2002, 97, 492.
16. Licata, A.; Bona, D.D.; Schepis, F.; Shahied, L.; Craxi, A.; Camma, C. J. Hepatol., 2003, 39, 1056.
17. Nomura, H.; Sou, S.; Tanimoto, H.; Nagahama, T.; Kimura, Y.; Hayashi, J.; Ishibashi, H.; Kashiwagi, S. Hepatology, 2004, 39, 1213.
18. Harris, S.; Robins, R. K. Ribavirin: structure and antiviral activity relationships. In Ribavirin: A Broad Spectrum Antiviral Agent; Smith, R. A.; Kirkpatrick, W., Eds.; Academic Press: New York, 1980; Vol. 13, pp. 1-21.
19. Caliceti, P. Dig. Liver. Dis., 2004, 36, 3, 334.
20. Youngster, S.; Wang, Y.S.; Grace, M.; Bausch, J.; Bordens, R.; Wyss, D.F. Curr. Pharm. Des., 2002, 8, 2139.
21. Santantonio, T.; Fasano, M.; Sinisi, E.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G. J. Hepatol., 2005, 42, 329.
22. Scotto, G.; Palumbo, E.; Fazio, V.; Cibelli, D.C.; Saracino, A.; Angarano, G. Infection, 2005, 33, 30.
23. Wiegand, J.; Buggisch, P.; Boecher, W.; Zeuzem, S.; Gelbmann, C.M.; Berg, T.; Kauffmann, W.; Kallinowski, B.; Cornberg, M.; Jaeckel, E.; Wedemeyer, H.; Manns, M.P. Hepatology, 2006, 43, 250.
24. Kamal, S.M.; Fouly, A.E.; Kamel, R.R.; Hockenjos, B.; Al Tawil, A.; Khalifa, K.E.; He, Q.; Koziel, M.J.; El Naggar, K.M.; Rasenack, J.; Afdhal, N.H. Gastroenterology, 2006, 130, 632.
25. De Rosa, F.G.; Bargiacchi, O.; Audagnotto, S.; Gavazzino, S.; Cariti, G.; Raiteri, R.; Di Pierri, G.-J. Antimicrob. Chemother., 2006, 57, 360.
26. Cariti, G.; Quaglia, S.; Meoli, I.; Veronese, L.; Audagnotto, S.; De Blasi, T.; Mancardi, R.; Reiteri, R.; Di Pierri, G. J. Biol. Regul. Homeost. Agents, 2003, 17, 188.
27. Kamal, S.M.; Moustafa, K.N.; Chen, J.; Fehr, J.; Abdel Moneim, A.; Khalifa, K.E.; El Gohary, L.A.; Ramy, A.H.; Madwar, M.A.; Rasenack, J.; Afdhal, N.H. Hepatology, 2006, 43, 923.
28. Corey, K.E.; Ross, A.S.; Wurcel, A.; Schulze Zur Wiesch, J.; Kim, A.Y.; Lauer, G.M.; Chung, R.T. Clin. Gastroenterol. Hepatol., 2006, 4(10), 1278.
29. Satantonio, T. Curr. Pharm. Des., 2004, 10(17), 2077.
30. Palumbo, E.; Sinisi, E.; Guastadisegni, A.; Pastore, G.; Santantonio, T. Dig. Liver. Dis., 2002, 34, 78.